Previous JobJob TitleAssociate/Full Professor — Radiopharmaceutical Sciences / Radioligand Therapy (Tenure-Track) - MITC Next JobApply for JobJob ID61195 LocationColumbia Full/Part TimeFull-Time Add to My Favorite JobsEmail this Job Hiring Department University of Missouri-ColumbiaCollege of Arts and Science Department of ChemistryAssistant Professor - Molecular Imaging and Theranostics Center (MITC)
Radiopharmaceutical Sciences Job Description We are also recruiting two other roles for the MITC. These positions can be found by searching the job title or job ID number below:Assistant Professor – MITC (job ID 61193)Research Scientist – MITC (job ID 61198)The University of Missouri (MU) seeks applications and nominations for three coordinated positions in radiopharmaceutical sciences, broadly defined: an Assistant
Professor, an Associate/Full Professor (both tenure-track), and a Senior Research Scientist (non-tenure-track). Multiple appointments in each track are possible. These appointments are part of MizzouForward, the most important strategic investment to achieve research excellence and student success in the history of the university. This initiative will leverage existing institutional strengths and address national
health and scientific priority areas through innovation and collaboration. Successful candidates will have outstanding, competitive, externally funded research programs in any area of radiopharmaceutical sciences including, but not limited to, imaging, theranostics, radiobiology, and dosimetry. Positions are available in the Departments Chemistry and Physics in the College of Arts & Science, Departments of Chemical
and Biomedical Engineering in the College of Engineering and the Department of Biochemistry in the School of Medicine. Appointments and / or joint appointments in other departments are possible. A centerpiece of the University’s focus on radiopharmaceutical excellence is the University of Missouri research reactor (MURR) – the most powerful on a university campus in North America. MURR produces several medically
important isotopes such as Lu-177 and Tb-161. Recently, the University has built a world-class preclinical radiopharmaceutical development center: the Molecular Imaging and Theranostics Center (MITC). MITC hosts a full suite of radiochemistry and pre-clinical imaging capabilities. MITC partners with the NextGen Precision Health Initiative. Established in 2021, the NextGen Precision Health Institute (NGPHI) provides
Summary from the source posting. Always confirm details on the institution's official career page.